T
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Taurean Brown's research investigates the neurological and physiological impacts of chemotherapy, specifically focusing on cognitive dysfunction and inflammation in preclinical models. Brown has published on the implications of breast cancer chemotherapy on the gut, liver, and central nervous system, and has specifically examined cognitive impairment resulting from treatments like docetaxel, doxorubicin, and cyclophosphamide. Current work explores the potential of piperlongumine as a neuro-protectant agent against chemotherapy-induced cognitive impairment. Brown also contributes to research on laboratory techniques, including combined mechanical and enzymatic dissociation of mouse brain hippocampal tissue. Brown has a h-index of 5 and has authored 12 publications with 146 citations. Key collaborators at the University of Arkansas for Medical Sciences include Pilar Simmons, Fabio Ntag Fabio Ntagwabira, and Taylor H. McElroy, with whom Brown shares multiple publications.
Metrics
- h-index: 5
- Publications: 12
- Citations: 151
Selected Publications
-
Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment (2022)
-
Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue (2021)
-
Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue (2021)
-
Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide (2021)
-
Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System (2021)
Collaboration Network
Top Collaborators
Antiño R. Allen
University of Arkansas for Medical Sciences
5 shared publications
In database
- Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Taylor McElroy
University of Arkansas for Medical Sciences
4 shared publications
In database
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Pilar Simmons
University of Arkansas for Medical Sciences
4 shared publications
In database
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Fabio Ntagwabira
University of Arkansas for Medical Sciences
4 shared publications
In database
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Madison Trujillo
University of Arkansas for Medical Sciences (US)
3 shared publications
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
DeLawrence Sykes
Pomona College (US)
1 shared publication
- Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
Huddoy Walters
University of Arkansas for Medical Sciences (US)
1 shared publication
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
Jing Wang
University of Arkansas for Medical Sciences (US)
1 shared publication
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
Stephanie D. Byrum
University of Arkansas for Medical Sciences
1 shared publication
In database
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
Delawerence Sykes
Pomona College (US)
1 shared publication
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
Similar Researchers
Based on overlapping research topics
Fabio Ntagwabira
University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research
Neuroscience and Neuropharmacology Research
Cancer Treatment and Pharmacology
Antiño R. Allen
University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research
Neuroscience and Neuropharmacology Research
Cancer Treatment and Pharmacology
C. Keisling
Harding University Main Campus
Neuroscience and Neuropharmacology Research
Immune Response and Inflammation
Molecular Biology Techniques and Applications
Charles E. Hay
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Immune Response and Inflammation
Molecular Biology Techniques and Applications
Fabricio Medina‐ Bolivar
Arkansas State University
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
Pharmacological Effects and Toxicity Studies
Taylor McElroy
University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research
Neuroscience and Neuropharmacology Research
Cancer Treatment and Pharmacology